No Data
No Data
Rakovina Therapeutics Second-Quarter Loss Widens on Higher Spending
Rakovina Therapeutics Announces 2024 Q2 Financial Results and Provides Corporate Update
Rakovina Therapeutics Raises $2 Million in Oversubscribed Private Placement
Rakovina Therapeutics Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
No Data